Zhejiang Conba Pharmaceutical Co., Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Conba Pharmaceutical Co., Ltd. with three other
companies in this sector in China:
KPC Pharmaceuticals Inc
sales of 4.92 billion Chinese Renmimbi [US$729.47 million]
of which 51%
was Drugs Wholesale and Retail),
Dong-E-E-Jiao Co Ltd
(5.45 billion Chinese Renmimbi [US$808.40 million]
of which 88%
was Medicine Manufacturing), and
Zhejiang Medicine Co., Ltd.
(4.50 billion Chinese Renmimbi [US$667.15 million]
of which 41%
Zhejiang Conba Pharmaceutical Co., Ltd. reported sales of 5.30 billion Chinese Renmimbi (US$786.72 million)
December of 2015.
increase of 48.0%
versus 2014, when the company's sales were 3.58 billion Chinese Renmimbi.
Sales at Zhejiang Conba Pharmaceutical Co., Ltd. have increased during each of the previous five years
(and since 2010, sales have increased a total of 195%).
Sales of Commerce saw an increase
that was more than double the company's growth rate: sales were up
856.6% in 2015, from
160.97 million Chinese Renmimbi to 1.54 billion Chinese Renmimbi.
Not all segments of Zhejiang Conba Pharmaceutical Co., Ltd. experienced an increase in sales in 2015:
sales of Other fell 64.6% to 14.99 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).